Acupuncture for Treatment of Chronic LBP, RCT, Single Blinded

A Randomized, Single Blind, Controlled Clinical Trial to Evaluate the Pain Relief Efficacy, Functional Improvement and Safety of Acupuncture in Patients With Chronic Low Back Pain

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00353847

Enrollment

Registered

2006-07-19

Start date

2006-07-31

Completion date

Unknown

Last updated

2006-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

acupuncture, RCTs, chronic LBP

Brief summary

The purpose of this study is to determine whether acupuncture is effective and safe in the treatment of chronic LBP.

Detailed description

The purpose of this study is as follows: 1. pain : VAS 2. Function : Roland Disability Scale 3. Side effect 4. Validity

Interventions

DEVICEAcupuncture

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Having chronic, non-specific, LBP of at least 3 months' duration over 20 years old. * Back pain must be the chief complaint * Having normal neurological test * Having signature voluntarily an IRB-approved consent form at enrollment

Exclusion criteria

* Potential spinal disease (e.g. a spinal tumor, infection or fracture etc) * Other diseases (e.g. bleeding disease, dementia,epilepsy, neurogenic disorder etc) * Planned or got lumbar surgery * The prior use of acupuncture within the past 6 months * Inflammatory arthritis * The current use of systematic corticosteroids, narcotics, anticoagulants, muscle relaxants * The involvement in legal problem related to LBP * Refusal to be randomized

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale, RDQ scale	—

Secondary

Measure	Time frame
Patient Global Assessment	—

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026